Bukwang Pharmaceutical to Strengthen OTC Marketing for Tasynol and Tabex Gel
"Strengthening Brand Competitiveness"
Bukwang Pharmaceutical is strengthening its over-the-counter (OTC) business by maintaining the pharmacy supply price of its antipyretic and analgesic "Tasynol," even as price increases for OTC drugs continue.
On August 3, Bukwang Pharmaceutical announced that it will reinforce the marketing of Tasynol, an acetaminophen-based antipyretic and analgesic, and Tabex Gel, a topical anti-inflammatory analgesic.
Although the retail price of some OTC drugs has recently risen, Bukwang Pharmaceutical has decided to keep the existing pharmacy supply price for Tasynol. The strategy is to use price competitiveness to reduce the burden on both pharmacies and consumers while increasing its market share.
During the COVID-19 pandemic, Bukwang Pharmaceutical continued the supply of acetaminophen by leveraging its own production facilities when a shortage occurred.
In addition, the company will expand marketing for Tabex Gel, its topical anti-inflammatory analgesic.
Hot Picks Today
"Banks Roll Out 'High-Interest Specials' Offering Up to 7-13% a Year: 'Why Not Choose Savings Over Stocks?'"
- "Annual Average Sales Exceed 7.5 Billion Won": Olive Young in This Area Far Outperforms Even Seoul
- Soojung Lee Raises Doubts about Jang Miran's Cause of Death: "A Young Woman Hanging Herself from a Palm Tree at Night? That's Laughable"
- [Click eStock] "Rejuran Cosmetics to Be New Growth Pillar" Sangsangin Securities Raises Target Price for Pharma Research
- "Even If It Costs More Than the Drink... Chinese Millennials and Gen Z Drive Trend for 'Stickers' Pricier Than Beverages"
Bukwang Pharmaceutical plans to strengthen its nationwide pharmacy distribution network through a strategic sales partnership with Shinshin Pharmaceutical.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
